Bausch Health Companies Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Bausch Health Companies Inc. (BHC) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $756.30 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-10-24.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2014-10-24
- Bausch Health Companies Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2014-09-30 was $756.30M.
- Bausch Health Companies Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2014-06-30 was -$266.40M.
- Bausch Health Companies Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2014-03-31 was -$384.10M.
- Bausch Health Companies Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2013-12-31 was -$144.59M.
- Bausch Health Companies Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$5.38B.
- Bausch Health Companies Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2012 was -$2.97B.
- Bausch Health Companies Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2011 was -$2.81B, a 1326.75% decline from fiscal 2010.
- Bausch Health Companies Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2010 was $228.94M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2014-09-30 | $756.30M 10-Q · filed 2014-10-24 | $489.90M derived: sum of 2 quarters · filed 2014-10-24 | $105.80M 10-Q · filed 2014-10-24 | -$38.79M derived: sum of 4 quarters · filed 2014-10-24 | ||||
| 2014-06-30 | -$266.40M 10-Q · filed 2014-08-01 | -$650.50M 10-Q · filed 2014-08-01 | -$795.09M derived: sum of 3 quarters · filed 2014-08-01 | -$5.26B derived: sum of 4 quarters · filed 2014-10-24 | ||||
| 2014-03-31 | -$384.10M 10-Q · filed 2014-05-09 | -$528.69M derived: sum of 2 quarters · filed 2014-05-09 | -$5.00B derived: sum of 3 quarters · filed 2014-10-24 | -$5.53B derived: sum of 4 quarters · filed 2014-10-24 | ||||
| 2013-12-31 | -$144.59M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | -$4.61B derived: sum of 2 quarters · filed 2014-10-24 | -$5.15B derived: sum of 3 quarters · filed 2014-10-24 | -$5.38B 10-K · filed 2014-02-28 | ||||
| 2013-09-30 | -$4.47B 10-Q · filed 2014-10-24 | -$4.47B 10-Q · filed 2013-11-01 | -$5.00B derived: sum of 2 quarters · filed 2014-10-24 | -$5.24B 10-Q · filed 2014-10-24 | -$5.24B 10-Q · filed 2013-11-01 | -$7.21B derived: sum of 4 quarters · filed 2014-10-24 | ||
| 2013-06-30 | -$531.70M 10-Q · filed 2014-08-01 | -$531.73M 10-Q · filed 2013-08-07 | -$766.60M 10-Q · filed 2014-08-01 | -$766.63M 10-Q · filed 2013-08-07 | -$2.74B derived: sum of 3 quarters · filed 2014-08-01 | -$3.04B derived: sum of 4 quarters · filed 2014-08-01 | ||
| 2013-03-31 | -$234.90M 10-Q · filed 2014-05-09 | -$234.90M 10-Q · filed 2013-05-03 | -$2.21B derived: sum of 2 quarters · filed 2014-05-09 | -$2.51B derived: sum of 3 quarters · filed 2014-05-09 | -$2.98B derived: sum of 4 quarters · filed 2014-05-09 | |||
| 2012-12-31 | -$1.97B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | -$2.27B derived: sum of 2 quarters · filed 2014-02-28 | -$2.75B derived: sum of 3 quarters · filed 2014-02-28 | -$2.97B 10-K · filed 2014-02-28 | ||||
| 2012-09-30 | -$297.40M 10-Q · filed 2013-11-01 | -$773.54M derived: sum of 2 quarters · filed 2013-11-01 | -$991.92M 10-Q · filed 2013-11-01 | -$2.51B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | -$476.14M 10-Q · filed 2013-08-07 | -$694.52M 10-Q · filed 2013-08-07 | -$2.21B derived: sum of 3 quarters · filed 2014-02-28 | -$2.65B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | -$218.38M 10-Q · filed 2013-05-03 | -$1.73B derived: sum of 2 quarters · filed 2014-02-28 | -$2.18B derived: sum of 3 quarters · filed 2014-02-28 | -$2.20B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | -$1.51B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | -$1.96B derived: sum of 2 quarters · filed 2014-02-28 | -$1.98B derived: sum of 3 quarters · filed 2014-02-28 | -$2.81B 10-K · filed 2014-02-28 | -$2.84B 10-K · filed 2012-02-29 | |||
| 2011-09-30 | -$442.62M 10-Q · filed 2012-11-05 | -$469.12M derived: sum of 2 quarters · filed 2012-11-05 | -$1.29B 10-Q · filed 2012-11-05 | -$1.33B 10-Q · filed 2011-11-04 | -$1.33B derived: sum of 4 quarters · filed 2013-02-28 | |||
| 2011-06-30 | -$26.50M 10-Q · filed 2012-08-03 | -$851.83M 10-Q · filed 2012-08-03 | -$885.03M derived: sum of 3 quarters · filed 2013-02-28 | -$569.66M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | -$825.33M 10-Q · filed 2012-05-04 | -$858.53M derived: sum of 2 quarters · filed 2013-02-28 | -$543.16M derived: sum of 3 quarters · filed 2013-02-28 | |||||
| 2010-12-31 | -$33.20M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $282.17M derived: sum of 2 quarters · filed 2013-02-28 | $228.94M 10-K · filed 2013-02-28 | |||||
| 2010-09-30 | $315.37M 10-Q · filed 2011-11-04 | $262.13M 10-Q · filed 2011-11-04 | ||||||
| 2009-12-31 | -$742.77M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |